Literature DB >> 7492311

Synthesis of a Cys949Tyr alpha 2-macroglobulin thiol ester mutant: co-transfection with wild-type alpha 2-macroglobulin in an episomal expression system.

L Van Rompaey1, H Van den Berghe, P Marynen.   

Abstract

A full-length alpha 2-macroglobulin (alpha 2M) cDNA was cloned into the episomal expression vectors pREP7 and pMEP4. Electroporation of the cell lines WI-L2-729HF2, U-937, K-562 and an Epstein-Barr virus-transformed cell line resulted in stable transfectants only with K-562 cells. Stable expression was obtained exclusively with pMEP4-alpha 2M and was driven from the inducible human metallothionein IIA promoter. Expression of the wild-type alpha 2M cDNA resulted in a recombinant protein (r alpha 2M) that could not be distinguished from plasma alpha 2M (p-alpha 2M): the transfected K-562 cells secreted tetrameric alpha 2M with intact internal thiol esters, a functional bait domain and a latent receptor-binding domain. r alpha 2M inhibited trypsin and elastase from cleaving a high-molecular-mass substrate. When the Cys-949 involved in the formation of the internal thiol ester was mutated to tyrosine (C949Y-r alpha 2M), a tetrameric alpha 2M was secreted, with the electrophoretic mobility of methylamine-treated p-alpha 2M (p-alpha 2M/MA) and with a functional receptor-binding domain. The C949Y-r alpha 2M did not possess proteinase-inhibiting capacity. Heterozygosity was mimicked by co-transfecting the K-562 cells with wild-type and mutant expression vectors. In this case, r alpha 2M was secreted with zero, one, two, three or four internal thiol esters. A comparison of the interaction of interleukin 1 beta and basic fibroblast growth factor with native p-alpha 2M, p-alpha 2M/MA and the mutant C949Y-r alpha 2M revealed that when assayed under nondenaturing conditions, no binding occurred to 'slow' p-alpha 2M whereas quantitatively similar binding was observed to 'fast' p-alpha 2M/MA and C949Y-r alpha 2M. Covalent binding, however, was essentially limited to p-alpha 2M/MA, suggesting the involvement of Cys-949 in the process. Covalent binding of insulin, on the contrary, was only observed when it was present during hydrolysis of the internal thiol esters of p-alpha 2M by trypsin treatment, and thus involves the activated Glx residue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492311      PMCID: PMC1136243          DOI: 10.1042/bj3120183

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Qualitative and quantitative study of the growth and cell surface properties of Huntington's disease fibroblasts and age-matched controls. Lack of significant differences.

Authors:  J J Cassiman; J Verlinden; R F Vlietinck; J Bellemans; F Van Leuven; J Deroover; F Baro; H Van den Berghe
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin.

Authors:  W Borth; T A Luger
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

3.  A monoclonal antibody to a neo-antigen on alpha 2-macroglobulin complexes inhibits receptor-mediated endocytosis.

Authors:  P Marynen; F Van Leuven; J J Cassiman; H Van den Berghe
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

4.  The effect of zinc and other divalent cations on the structure and function of human alpha 2-macroglobulin.

Authors:  C W Pratt; S V Pizzo
Journal:  Biochim Biophys Acta       Date:  1984-12-07

5.  Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli.

Authors:  P Wingfield; M Payton; J Tavernier; M Barnes; A Shaw; K Rose; M G Simona; S Demczuk; K Williamson; J M Dayer
Journal:  Eur J Biochem       Date:  1986-11-03

6.  Purification and characterization of human recombinant interleukin-1 beta.

Authors:  C A Meyers; K O Johanson; L M Miles; P J McDevitt; P L Simon; R L Webb; M J Chen; B P Holskin; J S Lillquist; P R Young
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

7.  Specific covalent binding of platelet-derived growth factor to human plasma alpha 2-macroglobulin.

Authors:  J S Huang; S S Huang; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Human alpha-2-macroglobulin. Studies on the electrophoretic heterogeneity.

Authors:  L P Nelles; P K Hall; R C Roberts
Journal:  Biochim Biophys Acta       Date:  1980-05-29

9.  Relation of internal thioesters to conformational change and receptor-recognition site in alpha 2-macroglobulin complexes.

Authors:  F Van Leuven; P Marynen; J J Cassiman; H Van den Berghe
Journal:  Biochem J       Date:  1982-05-01       Impact factor: 3.857

10.  Enzyme-linked immunosorbent assay (ELISA) for the measurement of small quantities of alpha 2-macroglobulin.

Authors:  C Munck Petersen; J Vestergård Povlsen; J Ingerslev
Journal:  Scand J Clin Lab Invest       Date:  1985-12       Impact factor: 1.713

View more
  3 in total

1.  Native conformations of human complement components C3 and C4 show different dependencies on thioester formation.

Authors:  L Isaac; D Aivazian; A Taniguchi-Sidle; R O Ebanks; C S Farah; M P Florido; M K Pangburn; D E Isenman
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

2.  Inhibition of intracellular proteolytic processing of soluble proproteins by an engineered alpha 2-macroglobulin containing a furin recognition sequence in the bait region.

Authors:  L Van Rompaey; T Ayoubi; W Van De Ven; P Marynen
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Design of a new protease inhibitor by the manipulation of the bait region of alpha 2-macroglobulin: inhibition of the tobacco etch virus protease by mutant alpha 2-macroglobulin.

Authors:  L Van Rompaey; P Proost; H Van den Berghe; P Marynen
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.